• Adobe Inc.: Barclays downgrades to market weight from overweight and reduces the target price from USD 335 to USD 275.
  • Air Products & Chemicals, Inc.: Wells Fargo upgrades to overweight from equalweight and raises the target price from USD 270 to USD 325.
  • Alcoa: JP Morgan upgrades to neutral from underweight and raises the target price from USD 50 to USD 68.
  • Celanese Corporation: Wells Fargo upgrades to overweight from equalweight and raises the target price from USD 55 to USD 70.
  • Flagstar Bank, National Association: Keefe Bruyette & Woods upgrades to outperform from market perform and raises the target price from USD 14 to USD 16.
  • Linde Plc: JP Morgan upgrades to overweight from neutral with a price target raised from USD 455 to USD 525.
  • Oracle Corporation: CITIC Securities Co Ltd upgrades to buy from hold with a target price of USD 200.
  • Qiagen N.v.: Deutsche Bank upgrades to buy from hold with a target price of USD 54.
  • Casey's General Stores, Inc.: Wolfe Research maintains its outperform rating and raises the target price from USD 638 to USD 808.
  • Dow Inc.: Wells Fargo maintains its overweight recommendation and raises the target price from USD 30 to USD 45.
  • Hims & Hers Health, Inc.: First Shanghai Securities maintains its buy recommendation and reduces the target price from USD 56.80 to USD 31.10.
  • Lyondellbasell Industries N.v.: Wells Fargo maintains its equalweight recommendation and raises the target price from USD 48 to USD 70.
  • Revolution Medicines, Inc.: Wolfe Research maintains its outperform rating and raises the target price from USD 75 to USD 110.
  • Rubrik, Inc.: BMO Capital Markets maintains its outperform rating and reduces the target price from USD 105 to USD 70.
  • Sentinelone, Inc.: Canaccord Genuity maintains its buy recommendation and reduces the target price from USD 23 to USD 17.
  • Venture Global, Inc.: RBC Capital maintains its outperform rating and raises the target price from USD 11 to USD 14.
  • Whirlpool Corporation: JP Morgan maintains its neutral recommendation and reduces the target price from USD 76 to USD 59.